帕金森病中运动皮层突触前抑制受损。
Impaired presynaptic inhibition in the motor cortex in Parkinson disease.
作者信息
Chu J, Wagle-Shukla A, Gunraj C, Lang A E, Chen R
机构信息
Division of Neurology, Department of Medicine, University of Toronto and Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada.
出版信息
Neurology. 2009 Mar 3;72(9):842-9. doi: 10.1212/01.wnl.0000343881.27524.e8.
OBJECTIVE
Intracortical inhibition in the motor cortex may be measured with short interval intracortical inhibition (SICI), likely mediated by GABA(A) receptors, and long interval intracortical inhibition (LICI), likely mediated by GABA(B) receptors. Separate neuronal populations mediate SICI and LICI, and LICI inhibits SICI, likely through GABA(B) mediated presynaptic inhibition. The purpose of this study was to test the hypothesis that cortical presynaptic inhibition in Parkinson disease (PD) is impaired.
METHODS
Eleven patients with PD were studied at rest both OFF and ON dopaminergic medications and the results were compared to nine healthy, age-matched controls. Motor evoked potentials were recorded from the first dorsal interosseous muscle and a triple-stimulus transcranial magnetic stimulation paradigm was used to evaluate SICI in the presence of LICI. The interstimulus interval (ISI) for SICI was 2 msec and LICI was studied at 100 (LICI(100)) and 150 msec (LICI(150)) ISIs.
RESULTS
There was no difference in SICI between the controls and PD ON and PD OFF groups. LICI(100) was stronger than LICI(150) and both were reduced in the PD ON and OFF groups. LICI(100) led to a much greater reduction in SICI in the control group compared to both the PD OFF and ON groups. LICI(150) caused no significant change in SICI with no significant difference between the controls and PD OFF and PD ON groups.
CONCLUSIONS
The inhibitory effect of long interval intracortical inhibition on short interval intracortical inhibition, likely representing presynpatic inhibition in the motor cortex, is decreased in Parkinson disease and may be a nondopaminergic feature of the disease.
目的
运动皮层内抑制可通过短间隔皮层内抑制(SICI)来测量,其可能由GABA(A)受体介导,以及长间隔皮层内抑制(LICI),其可能由GABA(B)受体介导。不同的神经元群体介导SICI和LICI,并且LICI抑制SICI,可能是通过GABA(B)介导的突触前抑制。本研究的目的是检验帕金森病(PD)中皮层突触前抑制受损这一假说。
方法
对11例PD患者在停用和使用多巴胺能药物时的静息状态进行研究,并将结果与9名年龄匹配的健康对照者进行比较。从第一背侧骨间肌记录运动诱发电位,并使用三刺激经颅磁刺激范式在存在LICI的情况下评估SICI。SICI的刺激间隔(ISI)为2毫秒,在100毫秒(LICI(100))和150毫秒(LICI(150))的ISI下研究LICI。
结果
对照组与PD用药组和未用药组之间的SICI无差异。LICI(100)强于LICI(150),且在PD用药组和未用药组中均降低。与PD未用药组和用药组相比,LICI(100)在对照组中导致SICI的降低幅度更大。LICI(150)未引起SICI的显著变化,对照组与PD未用药组和用药组之间无显著差异。
结论
帕金森病中长间隔皮层内抑制对短间隔皮层内抑制的抑制作用降低,这可能代表运动皮层中的突触前抑制,并且可能是该疾病的非多巴胺能特征。